This topic contains a solution. Click here to go to the answer

Author Question: Medlining practices __________. A) increase the likelihood that chronically ill low-income ... (Read 41 times)

tiara099

  • Hero Member
  • *****
  • Posts: 588
Medlining practices __________.
 
  A) increase the likelihood that chronically ill low-income patients will receive a basic level of appropriate medical treatment
  B) ensure that chronically ill low-income patients receive a high level of care regardless of their ability to pay
  C) are to the medical industry what redlining practices are in the banking and insurance industries
  D) are fundamental components of Medicare and Medicaid

Question 2

The negative consequences associated with managed care include the fact that __________.
 
  A) physicians are no longer able to act as a patients advocate
  B) decisions about patients are made by physicians and patients
  C) physicians are encouraged to treat fewer and fewer patients
  D) patients have less paperwork and lower administrative costs



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

macagn

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

Answer: C

Answer to Question 2

Answer: A




tiara099

  • Member
  • Posts: 588
Reply 2 on: Jul 2, 2018
Great answer, keep it coming :)


jamesnevil303

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Excellent

 

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library